Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Labs May Be Excluded from Revised Stark, AKS Rules

The Stark Law and Anti-Kickback Statute are being revised to support value-based care

CEO SUMMARY: When CMS and the OIG issued proposed rules last fall to make it easier for providers to participate in value-based and coordinated care arrangements, they considered excluding clinical labs, pharma companies, and DME firms because of concerns that the proposed rules could promote lab test fraud. Now, labs will have to wait for …

Labs May Be Excluded from Revised Stark, AKS Rules Read More »

To access this post, you must purchase The Dark Report.

Comments

;